EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, cilt.129, sa.9, ss.644-650, 2021 (SCI-Expanded)
Purpose To evaluate the effectiveness of cabergoline and the parameters affecting cabergoline response as add-on treatment to somatostatin analaogues (SSA) in patients with acromegaly uncontrolled with SSAs.